PJSC Surgutneftegas

  • WKN: 904596
  • ISIN: US8688612048
  • Land: Russia

Nachricht vom 13.05.2015 | 07:55

OJSC Surgutneftegas: Information statement on the meeting of the Issuer’s Board of Directors and its agenda

OJSC Surgutneftegas  / Miscellaneous

13.05.2015 07:55

Dissemination of a Regulatory Announcement, transmitted by
EquityStory.RS, LLC - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Information statement on the meeting of the Issuer's Board of Directors and its agenda The Board of Directors of OJSC 'Surgutneftegas' will hold its meeting on 15 May 2015. The agenda of the meeting of the Board of Directors of OJSC 'Surgutneftegas': 1. Preliminary approval of the annual report, review of the annual accounting statements, including the profit and loss accounts of OJSC 'Surgutneftegas' for 2014, audit opinions, the Auditing Committee's reports, and the annual report of the Audit Committee of the Board of Directors. 2. Review of proposed distribution of profit (loss) of OJSC 'Surgutneftegas', including recommendations for the shareholders regarding the size, form, period, and procedure for payment of dividends on shares of each category. 3. Nomination of the auditor. 4. Approval of draft resolutions proposed to the annual general shareholders' meeting, the form and text of ballot papers, the scope of documents and information to be made available to persons entitled to participate in the annual general shareholders' meeting. 5. Organizational arrangements for the annual general shareholders' meeting. 13.05.2015 The EquityStory.RS, LLC Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: OJSC Surgutneftegas Grigoriya Kukuyevitskogo, 1, bld.1 628415 Surgut Russia Phone: Fax: E-mail: Internet: www.surgutneftegas.ru ISIN: US8688612048 Category Code: MSC TIDM: SGGD Sequence Number: 2666 Time of Receipt: May 13, 2015 07:55:45 End of Announcement EquityStory.RS, LLC News-Service

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie


Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021